课题基金 / 基金详情

Canadian Immunization Research Network

Canadian Immunization Research Network
加拿大免疫研究网络
批准号：
302856
负责人：
Halperin Scott A
金额：
$0.0万
依托单位：
Dalhousie University (Nova Scotia)
依托单位国家：
加拿大
项目类别：
Miscellaneous Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-12-01 至 2014-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=302856&lang=en
关键词：
Adverse Events Following Immunization Immunogenicity Population-Based Methodology Rapid Response Research Capacity Vaccine Coverage Vaccine Effectiveness Vaccine Hesitancy Vaccine Safety Vulnerable Populations

项目摘要

项目成果

Halperin Scott A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Canadian Immunization Research Network (CIRN) represents over 150 investigators from more than 40 Canadian institutions, comprising leading experts in vaccine-related evaluative research from a wide array of disciplines. CIRN facilitates collaborative
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canadian Immunization Research Network: directed grant extension
  • 批准号：
    450714
  • 项目类别：
    Directed Grant
  • 资助金额：
    $0.0万
  • 财政年份：
    2021
  • 负责人：
    Halperin Scott A
  • 依托单位：
    Dalhousie University (Nova Scotia)
Trust, Acceptance and Sufficiency: Law as a Barrier to, and Enabler of, Routine and Responsive Immunization including COVID-19A
  • 批准号：
    432280
  • 项目类别：
    Directed Grant
  • 资助金额：
    $0.0万
  • 财政年份：
    2020
  • 负责人：
    Halperin Scott A
  • 依托单位：
    Dalhousie University (Nova Scotia)
Understanding the effects of public health outbreak control policies and implementation on individuals and communities: a path to improving COVID-19 policy effectiveness
  • 批准号：
    422616
  • 项目类别：
    Operating Grants
  • 资助金额：
    $0.0万
  • 财政年份：
    2020
  • 负责人：
    Halperin Scott A
  • 依托单位：
    Dalhousie University (Nova Scotia)
Canadian Immunization Research Network: COVID-19 Vaccine Readiness
  • 批准号：
    433192
  • 项目类别：
    Directed Grant
  • 资助金额：
    $0.0万
  • 财政年份：
    2020
  • 负责人：
    Halperin Scott A
  • 依托单位：
    Dalhousie University (Nova Scotia)
海外基金